Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato(trans-R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles

This publication has 28 references indexed in Scilit:

• Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model
  Cancer Chemotherapy and Pharmacology, 2002
• Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
  2002
• Intraperitoneal chemohyperthermia: rationale, technique, indications, and results.
  2001
• Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery
  Cancer, 1997
• Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
  New England Journal of Medicine, 1996
• Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy
  Annals of Surgery, 1995
• Comparative intraperitoneal pharmacokinetics of three platinum analogues
  Cancer Chemotherapy and Pharmacology, 1991
• Intraperitoneal Cisplatin and Carboplatin in the Management of Ovarian Cancer
  Published by Springer Nature ,1991
• INCREASED CYTO-TOXICITY AND REVERSAL OF RESISTANCE TO CIS-DIAMMINEDICHLORO-PLATINUM(II) WITH ENTRAPMENT OF CIS-BIS-NEODECANOATO-TRANS-R,R-1,2-DIAMINOCYCLOHEXANEPLATINUM(II) IN MULTILAMELLAR LIPID VESICLES
  1988
• Pharmacokinetics of carboplatin after intraperitoneal administration
  Cancer Chemotherapy and Pharmacology, 1988